{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:21:17Z","timestamp":1777670477791,"version":"3.51.4"},"reference-count":151,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The propensity towards platelet-rich thrombus formation increases substantially during normal ageing, and this trend is mediated by decreases in platelet responsiveness to the anti-aggregatory nitric oxide (NO) and prostacyclin (PGI2) pathways. The impairment of soluble guanylate cyclase and adenylate cyclase-based signalling that is associated with oxidative stress represents the major mechanism of this loss of anti-aggregatory reactivity. Platelet desensitization to these autacoids represents an adverse prognostic marker in patients with ischemic heart disease and may contribute to increased thrombo-embolic risk in patients with heart failure. Patients with platelet resistance to PGI2 also are unresponsive to ADP receptor antagonist therapy. Apart from ischemia, diabetes and aortic valve disease are also associated with impaired anti-aggregatory homeostasis. This review examines the association of impaired platelet cyclic nucleotide (i.e., cGMP and cAMP) signalling with the emerging evidence of thromboembolic risk in cardiovascular diseases, and discusses the potential therapeutic strategies targeting this abnormality.<\/jats:p>","DOI":"10.3390\/ijms23031042","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T22:46:32Z","timestamp":1642545992000},"page":"1042","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease"],"prefix":"10.3390","volume":"23","author":[{"given":"Yuliy Y.","family":"Chirkov","sequence":"first","affiliation":[{"name":"Cardiology Laboratory, Basil Hetzel Institute, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide 5011, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Cardiology Laboratory, Basil Hetzel Institute, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide 5011, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Cardiology Laboratory, Basil Hetzel Institute, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide 5011, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mohan, G., Malayala, S.V., Mehta, P., and Balla, M. (2020). A Comprehensive Review of Congenital Platelet Disorders, Thrombocytopenias and Thrombocytopathies. Cureus, 12.","DOI":"10.7759\/cureus.11275"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1160\/TH09-03-0192","article-title":"Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis","volume":"102","author":"Jennings","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rana, A., Westein, E., Niego, B., and Hagemeyer, C.E. (2019). Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities. Front. Cardiovasc. Med., 6.","DOI":"10.3389\/fcvm.2019.00141"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-0034-1389082","article-title":"Aging of platelet nitric oxide signaling: Pathogenesis, clinical implications, and therapeutics","volume":"40","author":"Procter","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vph.2013.10.002","article-title":"Clopidogrel \u201cresistance\u201d: Pre- vs post-receptor determinants","volume":"59","author":"Hurst","year":"2013","journal-title":"Vasc. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(98)00635-4","article-title":"Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction","volume":"33","author":"Ault","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1053\/euhj.2002.3259","article-title":"A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy","volume":"23","author":"Kamath","year":"2002","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijcard.2007.06.020","article-title":"Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation","volume":"126","author":"Ohara","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1067\/mhj.2002.121261","article-title":"Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes?","volume":"143","author":"Gurbel","year":"2002","journal-title":"Am. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/bph.15388","article-title":"Impairment of platelet NO signalling in coronary artery spasm: Role of hydrogen sulphide","volume":"178","author":"Imam","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2004.02.052","article-title":"Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction","volume":"93","author":"Chirkov","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0735-1097(01)01238-4","article-title":"Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets","volume":"37","author":"Chirkov","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2014.10.137","article-title":"Impaired platelet nitric oxide response in patients with new onset atrial fibrillation","volume":"179","author":"Procter","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2362.2004.01370.x","article-title":"Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: Possible role in platelet hyperactivation in obesity","volume":"34","author":"Anfossi","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2006.08.053","article-title":"The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration","volume":"49","author":"Worthley","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00005344-199506000-00015","article-title":"Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1","volume":"25","author":"Chirkov","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2174\/138945006778559111","article-title":"The many antithrombotic actions of nitric oxide","volume":"7","author":"Tziros","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.98.15.1481","article-title":"Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes","volume":"98","author":"Freedman","year":"1998","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37430","DOI":"10.1074\/jbc.M506518200","article-title":"Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation","volume":"280","author":"Marjanovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0049-3848(95)90868-G","article-title":"Nitric oxide release from resting human platelets","volume":"77","author":"Zhou","year":"1995","journal-title":"Thromb. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/09537104.2014.974024","article-title":"Human blood platelets lack nitric oxide synthase activity","volume":"26","author":"Gambaryan","year":"2015","journal-title":"Platelets"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1538-7836.2008.03014.x","article-title":"NO-synthase-\/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity","volume":"6","author":"Gambaryan","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/cvr\/cvx179","article-title":"Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation","volume":"113","author":"Lesyk","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0049-3848(03)00284-6","article-title":"Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects","volume":"110","author":"Anfossi","year":"2003","journal-title":"Thromb. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00005344-199303000-00006","article-title":"Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris","volume":"21","author":"Chirkov","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00004872-199312000-00008","article-title":"Inhibition by nitroprusside of platelet calcium mobilization: Evidence for reduced sensitivity to nitric oxide in essential hypertension","volume":"11","author":"Woods","year":"1993","journal-title":"J. Hypertens."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9149(00)01321-7","article-title":"Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis","volume":"87","author":"Raitakari","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","article-title":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease","volume":"101","author":"Britten","year":"2000","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/01.ATV.0000193622.77294.57","article-title":"Platelet nitric oxide responsiveness: A novel prognostic marker in acute coronary syndromes","volume":"25","author":"Willoughby","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2012.12.015","article-title":"Premature aging of cardiovascular\/platelet function in polycystic ovarian syndrome","volume":"126","author":"Chan","year":"2013","journal-title":"Am. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.amjmed.2014.11.007","article-title":"Reversal of hyperglycemia: Effects on nitric oxide signaling","volume":"128","author":"Chong","year":"2015","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.09.010","article-title":"Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects","volume":"204","author":"Rajendran","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1440-1681.2003.03859.x","article-title":"Pilot study examining the effect of cholesterol lowering on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild hypercholesterolaemia","volume":"30","author":"Stepien","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_34","first-page":"557","article-title":"Altered nitric oxide\/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes","volume":"99","author":"Bergandi","year":"2010","journal-title":"Clin. Res. Cardiol. Off. J. Ger. Card. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jcmg.2009.03.016","article-title":"Determinants of occurrence of aortic sclerosis in an aging population","volume":"2","author":"Ngo","year":"2009","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_36","first-page":"43","article-title":"Pathogenesis of aortic sclerosis: Association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activation","volume":"2","author":"Sverdlov","year":"2012","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/164_2018_197","article-title":"Soluble Guanylate Cyclase Stimulators and Activators","volume":"264","author":"Sandner","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1074\/jbc.M809460200","article-title":"Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells","volume":"284","author":"Maron","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1073\/pnas.0703944104","article-title":"Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation","volume":"104","author":"Sayed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCRESAHA.108.175133","article-title":"Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance","volume":"103","author":"Sayed","year":"2008","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature12722","article-title":"Dysfunctional nitric oxide signalling increases risk of myocardial infarction","volume":"504","author":"Erdmann","year":"2013","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1538-7836.2010.03806.x","article-title":"Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition","volume":"8","author":"Dangel","year":"2010","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.100.2.129","article-title":"Nitrate resistance in platelets from patients with stable angina pectoris","volume":"100","author":"Chirkov","year":"1999","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10557-008-6098-7","article-title":"Platelet hyperaggregability: Impaired responsiveness to nitric oxide (\u201cplatelet NO resistance\u201d) as a therapeutic target","volume":"22","author":"Rajendran","year":"2008","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2020.10.017","article-title":"Reviewing imaging modalities for the assessment of plaque erosion","volume":"318","author":"Collet","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11239-019-01969-9","article-title":"Relative risk of plaque erosion among different age and sex groups in patients with acute coronary syndrome","volume":"49","author":"Kim","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41569-021-00542-3","article-title":"Plaque erosion and acute coronary syndromes: Phenotype, molecular characteristics and future directions","volume":"18","author":"Fahed","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehx786","article-title":"Plaque erosion: A new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes","volume":"39","author":"Partida","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.10.016","article-title":"New prediction tools and treatment for ACS patients with plaque erosion","volume":"318","author":"Vergallo","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2020.11.002","article-title":"Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion","volume":"318","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","article-title":"Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1\u03b1 and Cathepsin G","volume":"38","author":"Folco","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.117.312494","article-title":"Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion","volume":"123","author":"Franck","year":"2018","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the Mechanisms of Acute Coronary Syndromes","volume":"124","author":"Libby","year":"2019","journal-title":"Circ. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s12265-020-10002-x","article-title":"High Plasma Myeloperoxidase Is Associated with Plaque Erosion in Patients with ST-Segment Elevation Myocardial Infarction","volume":"13","author":"Tan","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ajpath.2019.11.016","article-title":"Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding","volume":"190","author":"Flamion","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jcmg.2015.03.010","article-title":"OCT-Defined Morphological Characteristics of Coronary Artery Spasm Sites in Vasospastic Angina","volume":"8","author":"Shin","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhang, H., Bai, Z., Zhu, L., Liang, Y., Fan, X., Li, J., Wen, H., Shi, T., Zhao, Q., and Wang, Z. (2020). Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis. Eur. J. Med. Chem., 205.","DOI":"10.1016\/j.ejmech.2020.112665"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0735-1097(98)00101-6","article-title":"Increased oxidative stress in patients with congestive heart failure","volume":"31","author":"Keith","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1388-9842(03)00038-2","article-title":"Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure","volume":"6","author":"Anderson","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/cvr\/cvy087","article-title":"Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation","volume":"114","author":"Borgognone","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2012.01.066","article-title":"Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patients","volume":"60","author":"Willoughby","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.CIR.102.6.611","article-title":"Acute coronary findings at autopsy in heart failure patients with sudden death: Results from the assessment of treatment with lisinopril and survival (ATLAS) trial","volume":"102","author":"Uretsky","year":"2000","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9149(02)02536-5","article-title":"Association of aortic stenosis with platelet hyperaggregability and impaired responsiveness to nitric oxide","volume":"90","author":"Chirkov","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.hlc.2021.05.108","article-title":"Ageing, Hypertension and Aortic Valve Stenosis: A Conscious Uncoupling","volume":"30","author":"Hungerford","year":"2021","journal-title":"Heart Lung Circ."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/hrt.2004.057117","article-title":"Aortic sclerosis: Not an innocent murmur but a marker of increased cardiovascular risk","volume":"91","author":"Nightingale","year":"2005","journal-title":"Heart (Br. Card. Soc.)"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","article-title":"Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly","volume":"341","author":"Otto","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Velagic, A., Qin, C., Woodman, O.L., Horowitz, J.D., Ritchie, R.H., and Kemp-Harper, B.K. (2020). Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00727"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3132\/dvdr.2005.015","article-title":"Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes","volume":"2","author":"Anderson","year":"2005","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9149(00)00871-7","article-title":"Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2","volume":"86","author":"Rauch","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0735-1097(95)00518-8","article-title":"Platelet-dependent thrombin generation in patients with diabetes mellitus: Effects of glycemic control on coagulability in diabetes","volume":"27","author":"Aoki","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2007-979136","article-title":"Platelet aggregation in type 1 diabetes without microvascular disease during continuous subcutaneous insulin infusion","volume":"28","author":"Turk","year":"1996","journal-title":"Horm. Metab. Res. Horm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/hrt.59.6.663","article-title":"Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction","volume":"59","author":"Oswald","year":"1988","journal-title":"Br. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Barale, C., and Russo, I. (2020). Influence of Cardiometabolic Risk Factors on Platelet Function. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020623"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/eurheartj\/ehz961","article-title":"Inflamm-ageing: The role of inflammation in age-dependent cardiovascular disease","volume":"41","author":"Liberale","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Sverdlov, A.L., Ngo, D.T., Chan, W.P., Chirkov, Y.Y., and Horowitz, J.D. (2014). Aging of the nitric oxide system: Are we as old as our NO?. J. Am. Heart Assoc., 3.","DOI":"10.1161\/JAHA.114.000973"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Mongelli, A., Barbi, V., Gottardi Zamperla, M., Atlante, S., Forleo, L., Nesta, M., Massetti, M., Pontecorvi, A., Nanni, S., and Farsetti, A. (2021). Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.04.23.21255973"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/eurheartj\/ehaa534","article-title":"Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19","volume":"41","author":"Gue","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.bjp.0707687","article-title":"Probing the presence of the ligand-binding haem in cellular nitric oxide receptors","volume":"153","author":"Roy","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"43053","DOI":"10.1074\/jbc.M112.393892","article-title":"Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide","volume":"287","author":"Fernhoff","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1432-1033.1990.tb19276.x","article-title":"Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion","volume":"192","author":"Schmidt","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.CIR.95.4.885","article-title":"Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated","volume":"95","author":"Leo","year":"1997","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.RES.73.5.952","article-title":"Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries","volume":"73","author":"Yao","year":"1993","journal-title":"Circ. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0008-6363(97)00250-2","article-title":"Vasodilator dysfunction in aged spontaneously hypertensive rats: Changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production","volume":"37","author":"Bauersachs","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.RES.85.6.534","article-title":"Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats","volume":"85","author":"Ruetten","year":"1999","journal-title":"Circ. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/3-540-32967-6_7","article-title":"Nitric oxide and the vascular endothelium","volume":"176","author":"Moncada","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF00168445","article-title":"Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris","volume":"354","author":"Chirkov","year":"1996","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/0024-3205(95)02191-K","article-title":"Expression of constitutive endothelial nitric oxide synthase in human blood platelets","volume":"57","author":"Sase","year":"1995","journal-title":"Life Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.niox.2020.01.006","article-title":"Mechanisms of the protective effects of nitrate and nitrite in cardiovascular and metabolic diseases","volume":"96","author":"Liu","year":"2020","journal-title":"Nitric Oxide Biol. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/med.20151","article-title":"Nitrite as regulator of hypoxic signaling in mammalian physiology","volume":"29","author":"Bahrami","year":"2009","journal-title":"Med. Res. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000175890","article-title":"Evidence for plasma-mediated neutrophil superoxide anion production during myocardial infarction","volume":"82","author":"Siminiak","year":"1993","journal-title":"Cardiology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.CIR.90.2.694","article-title":"Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation","volume":"90","author":"Vaddi","year":"1994","journal-title":"Circulation"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/hh0901.090299","article-title":"Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways","volume":"88","author":"Sorescu","year":"2001","journal-title":"Circ. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1161\/01.RES.0000012569.55432.02","article-title":"Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling","volume":"90","author":"Mollnau","year":"2002","journal-title":"Circ. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.HYP.27.3.523","article-title":"Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide","volume":"27","author":"Brosnihan","year":"1996","journal-title":"Hypertension"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.34.2.296","article-title":"Angiotensin-(1-7) is a modulator of the human renin-angiotensin system","volume":"34","author":"Roks","year":"1999","journal-title":"Hypertension"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.fjc.0000176729.51819.a6","article-title":"Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside","volume":"46","author":"Rajendran","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0735-1097(03)00333-4","article-title":"Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease","volume":"41","author":"Gokce","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","article-title":"Endothelial function: Cardiac events","volume":"111","author":"Lerman","year":"2005","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0735-1097(98)00206-X","article-title":"Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis","volume":"32","author":"Adams","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1161\/01.CIR.92.8.2087","article-title":"Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis","volume":"92","author":"Zeiher","year":"1995","journal-title":"Circulation"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Srihirun, S., Piknova, B., Sibmooh, N., and Schechter, A.N. (2018). Phosphorylated vasodilator-stimulated phosphoprotein (P-VASPSer239) in platelets is increased by nitrite and partially deoxygenated erythrocytes. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193747"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.niox.2014.05.005","article-title":"Hypoxic potentiation of nitrite effects in human vessels and platelets","volume":"40","author":"Dautov","year":"2014","journal-title":"Nitric Oxide Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13543776.2021.1866538","article-title":"Soluble guanylate cyclase stimulators and their potential use: A patent review","volume":"31","author":"Sandner","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1160\/TH05-01-0062","article-title":"Effect of nitroxyl on human platelets function","volume":"94","author":"Bermejo","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"21788","DOI":"10.1074\/jbc.M109.014282","article-title":"The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: Interactions at ferrous heme and cysteine thiols","volume":"284","author":"Miller","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","article-title":"NO-independent regulatory site on soluble guanylate cyclase","volume":"410","author":"Stasch","year":"2001","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_115","first-page":"v","article-title":"Handbook of Experimental Pharmacology 191. cGMP: Generators, effectors and therapeutic implications. Preface","volume":"191","author":"Schmidt","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajo.2018.05.015","article-title":"A Randomized, Controlled Phase I\/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or Glaucoma","volume":"192","author":"Stacy","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cardiores.2006.10.021","article-title":"ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT","volume":"73","author":"Ceconi","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjhyper.2006.09.020","article-title":"Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients","volume":"20","author":"Pasini","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09537100600936158","article-title":"Potentiation of platelet responsiveness to nitric oxide by angiotensin-(1-7) is associated with suppression of superoxide release","volume":"18","author":"Rajendran","year":"2007","journal-title":"Platelets"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1464-5491.2004.01382.x","article-title":"Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria","volume":"22","author":"Dogra","year":"2005","journal-title":"Diabet. Med. J. Br. Diabet. Assoc."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/hrt.2005.082560","article-title":"Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure","volume":"92","author":"Strey","year":"2006","journal-title":"Heart (Br. Card. Soc.)"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"H1425","DOI":"10.1152\/ajpheart.00783.2003","article-title":"ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles","volume":"286","author":"Tiefenbacher","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ahj.2021.06.010","article-title":"Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)","volume":"240","author":"Ananthakrishna","year":"2021","journal-title":"Am. Heart J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5273(86)90146-4","article-title":"Perhexiline maleate treatment for severe angina pectoris--correlations with pharmacokinetics","volume":"13","author":"Horowitz","year":"1986","journal-title":"Int. J. Cardiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure: A randomized, controlled trial of short-term use of a novel treatment","volume":"112","author":"Lee","year":"2005","journal-title":"Circulation"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2005.11.058","article-title":"Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation","volume":"531","author":"Kennedy","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1053\/euhj.2002.3296","article-title":"Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide","volume":"23","author":"Willoughby","year":"2002","journal-title":"Eur. Heart J."},{"key":"ref_131","first-page":"S54","article-title":"Endothelial dysfunction in diabetes mellitus","volume":"32","author":"Cosentino","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_132","first-page":"65","article-title":"Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism","volume":"10","author":"Kim","year":"2003","journal-title":"Endothel. J. Endothel. Cell Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2003.10.055","article-title":"Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet-subendothelium interaction","volume":"484","author":"Arrebola","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/hq0102.101546","article-title":"Inhibition of platelet-collagen interaction: An in vivo action of insulin abolished by insulin resistance in obesity","volume":"22","author":"Westerbacka","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1056-8727(01)00196-9","article-title":"Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function","volume":"16","author":"Trovati","year":"2002","journal-title":"J. Diabetes Complicat."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/0953710021000062905","article-title":"Molecular and biochemical evidence for the presence of type III adenylyl cyclase in human platelets","volume":"14","author":"Katsel","year":"2003","journal-title":"Platelets"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","article-title":"The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways","volume":"120","author":"Burkhart","year":"2012","journal-title":"Blood"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/09537104.2014.916792","article-title":"Compartmentalisation of cAMP-dependent signalling in blood platelets: The role of lipid rafts and actin polymerisation","volume":"26","author":"Raslan","year":"2015","journal-title":"Platelets"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Braune, S., K\u00fcpper, J.H., and Jung, F. (2020). Effect of Prostanoids on Human Platelet Function: An Overview. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239020"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/jpet.107.131904","article-title":"Activation and inhibition of adenylyl cyclase isoforms by forskolin analogs","volume":"325","author":"Pinto","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2007-1018778","article-title":"Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus","volume":"15","author":"Akai","year":"1983","journal-title":"Horm. Metab. Res. Horm."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0161-4630(81)90138-5","article-title":"Refractoriness of diabetic platelets to inhibitory prostaglandins","volume":"7","author":"Lagarde","year":"1981","journal-title":"Prostaglandins Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/oby.2009.302","article-title":"In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin","volume":"18","author":"Russo","year":"2010","journal-title":"Obesity"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"L739","DOI":"10.1152\/ajplung.00500.2020","article-title":"Disease-specific platelet signaling defects in idiopathic pulmonary arterial hypertension","volume":"320","author":"Aulak","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.diabet.2018.04.004","article-title":"Platelet function following induced hypoglycaemia in type 2 diabetes","volume":"44","author":"Kahal","year":"2018","journal-title":"Diabetes Metab."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/13543784.2020.1764533","article-title":"Selatogrel, a novel P2Y(12) inhibitor: A review of the pharmacology and clinical development","volume":"29","author":"Milluzzo","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10557-016-6671-4","article-title":"New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications","volume":"30","author":"Procter","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.thromres.2019.07.016","article-title":"Impaired adenylate cyclase signaling in acute myocardial ischemia: Impact on effectiveness of P2Y(12) receptor antagonists","volume":"181","author":"Imam","year":"2019","journal-title":"Thromb. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.thromres.2020.10.009","article-title":"Does high on-treatment platelet aggregability reflect poor individual response to clopidogrel?","volume":"196","author":"Nooney","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","article-title":"Adenosine-mediated effects of ticagrelor: Evidence and potential clinical relevance","volume":"63","author":"Cattaneo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1042\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:03:32Z","timestamp":1760133812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":151,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23031042"],"URL":"https:\/\/doi.org\/10.3390\/ijms23031042","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]}}}